Wells Fargo Trims Aflac Price Target

Analysts lower outlook for insurance provider's stock, citing mixed valuation signals

Apr. 10, 2026 at 2:12pm

A close-up photograph of heavy, industrial banking equipment and machinery, including gears, levers, and metal casings, conveying the tangible, mechanical nature of financial institutions and wealth management.The intricate inner workings of the financial industry, captured in a dramatic, industrial-style photograph, symbolize the complex machinery behind Aflac's insurance products and the broader banking landscape.Columbus Today

Wells Fargo & Company has lowered its price target for Aflac (NYSE:AFL) from $118.00 to $116.00, maintaining an 'equal weight' rating on the financial services provider's stock. The move comes as analysts see limited near-term upside potential for Aflac's shares despite the company's multi-year outperformance.

Why it matters

Aflac is a major player in the supplemental insurance market, and its stock performance is closely watched by investors. The Wells Fargo price target cut, while relatively small, signals that analysts see mixed valuation signals for the company and may temper expectations for further short-term gains.

The details

In a research note issued on Friday, Wells Fargo analysts reduced their price objective on Aflac shares from $118.00 to $116.00, while reiterating an 'equal weight' rating. The new $116.00 target price represents a potential upside of 4.13% from the stock's current trading level.

  • Wells Fargo published its updated research note on Aflac on April 10, 2026.

The players

Wells Fargo & Company

A major American multinational financial services company that provides various banking, investment, and mortgage products and services.

Aflac

An American insurance company that provides supplemental insurance products, including accident, dental, hospital, short-term disability, and vision insurance.

Got photos? Submit your photos here. ›

The takeaway

The Wells Fargo price target cut on Aflac, while modest, suggests analysts see limited near-term upside potential for the stock despite the company's strong multi-year performance. This could temper investor enthusiasm and signal a need to closely monitor Aflac's valuation metrics going forward.